| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
1 company
Schoch Charles is a Chief Financial Officer at Candel Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $374K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | CADL Candel Therapeutics, Inc. | See Remarks | Sell | 5,000 | $8.83 | $44,169.00 | -11.6% | -41.6% | -41.4% | |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | See Remarks | Sell | 9,511 | $7.22 | $68,716.97 | -18.1% | -38.1% | -25.7% | |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | See Remarks | Sell | 9,971 | $8.22 | $81,943.67 | -15.9% | -49.7% | -36.4% | |
| Jul 17, 2024 | CADL Candel Therapeutics, Inc. | See Remarks | Sell | 9,884 | $6.47 | $63,975.18 | -13.7% | -9.4% | +5.3% | |
| Jul 11, 2024 | CADL Candel Therapeutics, Inc. | See Remarks | Sell | 8,897 | $5.97 | $53,145.34 | -10.9% | +1.4% | -1.7% |